|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.3 USD | +2.34% |
|
-5.79% | +51.18% |
| 05-15 | Inogen, Inc. Announces Separation of Stanislav Glezer as Executive Vice President, R&D and Chief Medical Officer | CI |
| 05-07 | Transcript : Inogen, Inc., Q1 2024 Earnings Call, May 07, 2024 |
Inogen, Inc. provided revenue guidance for the second quarter of 2024. For the second quarter of 2024, the company expects revenue to be in the range of $81 million to $84 million.
| 1st Jan change | Capi. | |
|---|---|---|
| +51.18% | 196M | |
| -7.16% | 178B | |
| -1.23% | 107B | |
| -4.86% | 67.04B | |
| -4.28% | 47.23B | |
| +10.32% | 44.62B | |
| +8.14% | 42.5B | |
| +15.76% | 29.99B | |
| +15.53% | 25.22B | |
| -5.88% | 24.14B |
INOGEN, INC. 
